Explore the Knowledge Graph

Products

Every marketed product, with its clinical facts as data

Coverage

  • 570,000+ branded and generic products from regions such as the US, Canada, and Europe, each resolved through its ingredients to one drug record.
  • Stored at every level of detail, from the brand down to a single strength, each with its own ID.
  • Label facts as structured rows: 21,800+ indications, 171,000+ adverse effects, 9,500+ contraindications, and 2,200+ boxed warnings, linked out to other ontologies.
  • 1.39M+ structured drug-drug interactions, each with a severity, an evidence level for the type of source behind it, and management advice.

Where it connects

Product Celebrex capsule · oral
Drugs Every product resolved through its ingredient to one drug record
productCelebrex ingredientCelecoxib drugbank_idDB00482
strength200 mg dosage_formCapsule routeOral
Indications Approved uses with the kind of use and country
conditionOsteoarthritis (OA) meddra10031161 kindmanagement_of off_labelfalse countryUS +6 more indications
Adverse effects Each effect, with any rates the label reports: the drug on its own, or beside placebo, an active comparator, or both
effectDyspepsia meddra10013946 percent (experimental)8.8 percent (placebo)6.2 evidence_typeclinical_trial routeOral +219 more adverse effects
Boxed warnings and contraindications The risk a label boxes, and the patient or exposure it rules out

boxed warning

kindwarning conditionGastrointestinal Toxicity meddra10059024 +1 more boxed warning

contraindication

kindhypersensitivity valueNSAIDs regionUS routeOral +3 more contraindications
Companies The company on the label, resolved to its parent company
labellers.nameG.D. Searle LLC Division of Pfizer Inc companies.namePfizer

Zoom in

Product concepts for celecoxib
product_concept_drugbank_idtitlelevelingredientstrengthroutedosage_formbrand
DBPC0248475[Celebrex]1nullnullnullnullCelebrex
DBPC0024468Celecoxib1Celecoxibnullnullnullnull
DBPC0024472Celecoxib Capsule2CelecoxibnullnullCapsulenull
DBPC0037111Celecoxib 200 mg2Celecoxib200 mgnullnullnull
DBPC0248483Celecoxib Capsule [Celebrex]3CelecoxibnullnullCapsuleCelebrex
DBPC0248482Celecoxib 400 mg Oral [Celebrex]4Celecoxib400 mgOralnullCelebrex

+264 more product concepts

Celecoxib boxed warnings and contraindications
sourcekindcondition or hypersensitivitymeddraregionroute
structured_blackbox_warningswarningGastrointestinal Toxicity10059024[][]
structured_blackbox_warningswarningCardiovascular Toxicity[][][]
structured_contraindicationshypersensitivityNSAIDs[]USOral
structured_contraindicationshypersensitivitysulfonamides[]USOral
structured_contraindicationshypersensitivityAcetylsalicylic acid[]USOral
Celecoxib interactions
interacting_drugdrug_drugbank_idseverityevidence_levelaction
MethotrexateDB00563major1increase_serum_concentration
WarfarinDB00682moderate1increase_specific_adverse_effects
DigoxinDB00390moderate1decrease_excretion
FurosemideDB00695moderate1decrease_therapeutic_efficacy
LisinoprilDB00722moderate1increase_specific_adverse_effects
2,4-thiazolidinedioneDB11898minor2increase_therapeutic_efficacy

+1,894 more interactions

Celecoxib allergy presentations
source_namepresentationmeddraicd10hypersensitivity_type
NSAIDs (COX-2 Inhibitors)Anaphylaxis10002198[]Type I
NSAIDs (COX-2 Inhibitors)Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum[][]Type IV
NSAIDs (COX-2 Inhibitors)Drug-Induced Allergic Hepatitis (DIAH)10071198[]Type IV
Sulfonamide (Non-antibiotic)Urticaria10046735L50Type I
Sulfonamide (Non-antibiotic)Angioedema10002424T78.3Type I
Sulfonamide (Non-antibiotic)Allergic Skin Reaction10012438L20Unclassified
Celecoxib products by region
productstrengthdosage_formcountrycodelabeller
Celebrex100 mgCapsuleUSNDC 54569-4671A-S Medication Solutions
Celebrex200 mgCapsuleUSNDC 54569-4672A-S Medication Solutions
Act Celecoxib100 mgCapsuleCanadaDIN 02420155Teva Italia S.R.L.
Act Celecoxib200 mgCapsuleCanadaDIN 02420163Teva Italia S.R.L.

+940 more products

Also in this data

  • US drug labelsFDA-approved manufacturer label text: patient medication guides, prescribing information for health professionals, and supplementary sections such as clinical trials and toxicology.
  • Therapeutic categoriesThe FDA’s Established Pharmacologic Class, extended to cover other regions.
  • Drug categoriesATC codes, MeSH headings, and chemical taxonomy.
  • RxNorm conceptsProduct records mapped to RxCUIs.
  • Drug-food interactionsReported the same way as drug-drug interactions, with descriptions and management advice.
  • PharmacologyMechanism of action, metabolism, absorption, distribution, and elimination, with half-life, clearance, and LD50 as structured values.

Questions it answers

  • How do boxed warnings and contraindications compare across a drug class? Efficacy and safety benchmarking
  • Which effects are more common on the drug than on placebo, and by how much? Efficacy and safety benchmarking
  • Which marketed products contain an ingredient, and in which countries? Competitive clinical landscape

All figures pulled as of November 2026.

Get answers you can trust, every time.